Ipratropium
From Wikipedia, the free encyclopedia
|
Ipratropium
|
|
| Systematic (IUPAC) name | |
| [8-methyl-8-(1-methylethyl)- 8-azoniabicyclo[3.2.1] oct-3-yl] 3-hydroxy-2-phenyl-propanoate | |
| Identifiers | |
| CAS number | |
| ATC code | R01 R03 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C20H30NO3 |
| Mol. mass | 332.457 g/mol |
| SMILES | & |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Protein binding | 0 to 9% in vitro |
| Metabolism | Hepatic |
| Half life | 2 hours |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
B(US) |
| Legal status | |
| Routes | Inhalation |
Ipratropium (as ipratropium bromide, trade name Atrovent and Apovent[1]) is an anticholinergic drug.[2]
Contents |
[edit] Uses
It is administered by inhalation for the treatment of obstructive lung diseases.
Ipratropium is also combined with albuterol (salbutamol) (trade names Combivent and Duoneb) for the management of chronic obstructive pulmonary disease (COPD) and asthma.
Ipratropium is also combined with fenoterol (trade names Duovent and Berodual N) for the management of asthma.
[edit] Pharmacology
It acts by blocking muscarinic receptors in the lung, inhibiting bronchoconstriction and mucus secretion. It is a non-selective muscarinic antagonist, and does not diffuse into the blood, which prevents systemic side-effects. Ipratropium is a derivative of atropine[3] but is a quaternary amine and therefore does not cross the blood-brain barrier, which prevents central side-effects (anticholinergic syndrome). Ipratropium is considered a short-acting bronchodilator.[4][5]
[edit] Side effects
If ipratropium is inhaled, side-effects resembling those of other anticholinergics are minimal. However, dry mouth and sedation have been reported.
[edit] References
- ^ http://drugs-about.com/drugs/apovent.html
- ^ Baigelman W, Chodosh S (March 1977). "Bronchodilator action of the anticholinergic drug, ipratropium bromide (Sch 1000), as an aerosol in chronic bronchitis and asthma". Chest 71 (3): 324–8. PMID 138578. http://www.chestjournal.org/cgi/pmidlookup?view=long&pmid=138578.
- ^ Yamatake Y, Sasagawa S, Yanaura S, Okamiya Y (1977). "[Antiallergic asthma effect of ipratropium bromide (Sch 1000) in dogs (author's transl)]" (in Japanese). Nippon Yakurigaku Zasshi 73 (7): 785–91. PMID 145994.
- ^ Kerstjens HA, Bantje TA, Luursema PB, et al. (2007). "Effects of short-acting bronchodilators added to maintenance tiotropium therapy". Chest 132 (5): 1493–9. doi:. PMID 17890476.
- ^ Knott L (November 20, 2007). "Antimuscarinic Bronchodilators". PatientUK. EMIS. http://www.patient.co.uk/showdoc/40025112/. Retrieved on 2008-06-16.
|
||||||||||||||||||||||||||
|
|||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||

